Petros Pharmaceuticals, Inc. - PTPI Operating Profitability

Public company logo of Petros Pharmaceuticals Inc (PTPI)

The adjusted operating margin demonstrates the efficiency of Petros Pharmaceuticals (PTPI), where 0.00 represents the latest level. Stability is ensured by the full localization of logistics within the US. Growth is based on the expansion of Stendra sales and the implementation of B2B digitalization. Diversification through telemedicine services and men's health products provides additional resilience, minimizing business risks.

Petros Pharmaceuticals Inc (PTPI): Profitability of Operations from 07/04/2022 to 06/28/2025

Petros Pharmaceuticals (PTPI) - metric breakdowns and financial figures

- price and consensus price forecast:
Fundamental company valuation:Petros Pharmaceuticals Inc, PTPI
Core merchandise of Petros Pharma

Operating margin measures the share of profit from core operations relative to total revenue, demonstrating cost management efficiency before taxes and interest. By analyzing the operating margin trend for Petros Pharmaceuticals (PTPI), an investor assesses the business's resilience to rising ingredient costs and regulatory risks, which helps determine the company's margin of safety when scaling its over-the-counter portfolio.

Main competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Rate PTHL (Pheton Holdings)|Aptorum (APM) - Operating Profitability|LYRA (Lyra Therapeutics) - Operating Profitability|Operating Profitability Impact BioMedical Inc|TNF Pharmaceuticals - Operating Profit Margin|Operating Margin YCBD|Operating Margin PainReform Ltd. (PRFX)|Operating Profitability Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Operating Profit Margin|OptiNose - Operating Margin|Operating Profit Margin PIRS|PROC: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.